AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
Ciprofloxacin USP in Rwanda
4 products registered with RDA — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Aarciflox-500 Film-coated tablets, | RWANDA-FDA25/HM/0134/0017 | AARTI DRUGS LIMITED. | active | 4 Feb 2031 |
| Ciprofloxacin IV Solution for Intravenous Infusion | RWANDA-FDA25/HM/0190/0020 | PHARCO B INTERNATIONAL | active | 29 Sept 2030 |
| CIPROCIN OPHTHALMIC SOLUTION | Rwanda FDA-HMP-MA-1653 | Abacus Parenteral Drugs Ltd (APDL) | active | 16 Aug 2029 |
| ULTRAFLOX-500 Film Coated Tablets | Rwanda FDA-HMP-MA-1540 | BAL PHARMA LIMITED | active | 26 Jul 2029 |
Ciprofloxacin USP — RDA Registration Details
RDA (Rwanda) has 4 registered products containing Ciprofloxacin USP, of which 4 are currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track Ciprofloxacin USP registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.